Get the Stockscreener App
1.005
5.19%
-0.055
After Hours:
2.59
1.585
+157.71%
Dyadic International Inc De stock is traded at $1.005, with a volume of 145.60K.
It is down -5.19% in the last 24 hours and up +3.61% over the past month.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$1.06
Open:
$1.02
24h Volume:
145.60K
Relative Volume:
1.67
Market Cap:
$30.24M
Revenue:
$2.96M
Net Income/Loss:
$-6.87M
P/E Ratio:
-4.3696
EPS:
-0.23
Net Cash Flow:
$-7.49M
1W Performance:
-8.64%
1M Performance:
+3.61%
6M Performance:
-32.55%
1Y Performance:
-25.56%
1-Day Range:
$1.00
$1.07
1-Week Range:
$1.00
$1.20
52-Week Range:
$0.912
$2.20
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.65 | 833.82M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.82 | 120.57M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.152 | 320.01M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.63 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Is Dyadic International Inc. building a consolidation baseFree Trade Timing Strategy With Technical Data - Newser
Dyadic International Closes $5.3 Million Stock Offering - TipRanks
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewswire
Dyadic International, Inc. Announces Pricing of $5.75 Million Public Offering of Common Stock - Quiver Quantitative
Economic Sector Performance Dashboards - Yahoo Finance
Dyadic International prices public offering of 6 million shares - Investing.com Australia
Dyadic International prices public offering of 6 million shares By Investing.com - Investing.com Canada
Dyadic International Raises Capital: 6 Million Share Offering to Fuel Precision Protein Development - Stock Titan
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
Dyadic International launches public offering of common stock - Investing.com Australia
Dyadic International Announces Strategic Stock Offering: Biotech Platform Expansion Plans Revealed - Stock Titan
What high frequency data says about PRPLDaily Trade Monitor with Pattern Alerts - Newser
How volatile is Dyadic International Inc. stock compared to the marketAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International Receives Nasdaq Deficiency Notice - TipRanks
Dyadic International Shifts Focus to Commercial Enterprise - TipRanks
DYAI 8-K: Dyadic Shifts to Commercial Focus With C1 & Dapibus™ Platforms | AIRE SEC FilingForm 8-K - Stock Titan
Candel Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
What analysts say about The Real Brokerage Inc. stockOutstanding capital returns - jammulinksnews.com
P 500Short Term Profit Focus - Newser
Why EFC.PRD stock attracts strong analyst attentionStrategic High Profit Opportunities - Newser
Dyadic rebrands as Applied BioSolutions to focus on commercial growth By Investing.com - Investing.com Canada
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions - Yahoo Finance
Dyadic International shareholders approve board proposals at annual meeting - Investing.com
Millennium Management LLC Takes Position in Dyadic International, Inc. (NASDAQ:DYAI) - Defense World
Kopin Co. (NASDAQ:KOPN) Shares Acquired by Bank of America Corp DE - Defense World
Bank of America Corp DE Grows Stock Position in Potbelly Co. (NASDAQ:PBPB) - Defense World
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Jane Street Group LLC Has $51,000 Position in Altus Power, Inc. (NYSE:AMPS) - Defense World
Comprehensive Report Reviews the Biotechnology Research Investment Driving Specialty Enzymes Market Growth:... - WhaTech
Top Market Trend Impacting Enzyme Stabilizer Development in the Coming Years: Innovative Oral Enzyme Stabil... - WhaTech
Dyadic International Appoints New President Amid Strategic Shift - TipRanks
Dyadic appoints new president to drive growth - Investing.com Australia
Dyadic's Strategic Transformation: New President to Scale Ancillary Protein Business After Major Partnership Wins - Stock Titan
Protease Market to Projected to Reach USD 5,762.7 Million by 2030, Growing at a CAGR of 5.4% - newstrail.com
Specialty Enzymes Market Top Disruptive Technologies Shaping Industries (2025-2032) - newstrail.com
Dyadic International’s Earnings Call: Progress Amid Challenges - TipRanks
Dyadic International Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Dyadic Q1 2025 revenue misses, stock rises 3.85% - Investing.com Nigeria
Earnings call transcript: Dyadic Q1 2025 revenue misses, stock rises 3.85% By Investing.com - Investing.com South Africa
Dyadic Lands Major CEPI and Gates Foundation Grants as Protein Platform Nears Commercial Launch - Stock Titan
Dyadic International, Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 - Nasdaq
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Eagle-Tribune
Biotech Pioneer Dyadic Schedules Q1 2025 Earnings Call to Discuss Protein Manufacturing Progress - Stock Titan
Dyadic International director to retire in June - Investing.com Australia
Dyadic International director to retire in June By Investing.com - Investing.com India
Dyadic International Director Arindam Bose Announces Retirement - TipRanks
Dyadic International, Inc. (NASDAQ:DYAI) Sees Large Increase in Short Interest - Defense World
Captivision Inc. (NASDAQ:CAPTW) Short Interest Down 42.5% in March - Defense World
Short Interest in Capcom Co., Ltd. (OTCMKTS:CCOEF) Rises By 74.5% - Defense World
Dyadic International, Inc. CEO to Present at 2025 World Vaccine Congress on Advancements in Biomanufacturing for Vaccines - Nasdaq
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):